Efter 104 ugers behandling var alle 16 patienter, som blev rekrutteret til den forlængede undersøgelse, i live, og 10 ud af disse 16 patienter var fri for invasiv ventilation.
After 104 weeks of treatment, all 16 patients who enrolled in the extension study were alive and 10 of these 16 patients were free of invasive ventilatory support.